Use of derivatives of C2-substituted indan-1-ol systems for producing medicaments for the prophylaxis or the treatment of obesity

Details for Australian Patent Application No. 2002342615 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Jaehne, Gerhard; Bickel, Martin; Gossel, Matthias; Krone, Volker

Agent Watermark

Pub. Number AU-B-2002342615

PCT Number PCT/EP02/09199

PCT Pub. Number WO2003/020199

Priority 101 42 660.7 31.08.01 DE

Filing date 17 August 2002

Wipo publication date 18 March 2003

Acceptance publication date 26 October 2006

International Classifications

A61K 31/10 (2006.01)

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 101 42 660.7 31.08.01 DE

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002342615

26 October 2006 Application Accepted

  Published as AU-B-2002342615

22 February 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002342616-ONE-PIECE JOINT BODY

2002342614-METHOD FOR PREPARING STABLE DISPERSIONS OF METALLIC NANOPARTICLES, STABLE DISPERSIONS OBTAINED THEREFROM AND COATING COMPOSITIONS CONTAINING THEM